University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 10 of 17

COMPLETED NA

PNE Effectiveness Cluster Trial

NCT03168165
TERMINATED NA

The Development of a Cognitive Reassurance Training Program

NCT03256617
TERMINATED Phase 4

TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone

NCT03028012
COMPLETED NA

Testing a Positive Psychology-based Intervention for Couples Coping With Stroke

NCT03335358
COMPLETED NA

Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain

NCT02935621
COMPLETED Phase 2

Optimization of Spinal Manipulative Therapy Protocols

NCT02868034
TERMINATED NA

Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy

NCT03075176
COMPLETED NA

Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial

NCT03176901
COMPLETED NA

Propionibacterium Acnes in Shoulder Arthroplasty

NCT03057821
TERMINATED Phase 1

Propranolol for Treating Fibromyalgia Pain

NCT03029845
COMPLETED Early Phase 1

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin

NCT02970032
COMPLETED NA

Social & Behavioral Rhythms in Chronic Pain

NCT03022643
COMPLETED Phase 2

Hypovitaminosis D in Neurocritical Patients

NCT02881957
COMPLETED Phase 1

Burst Suppression Anesthesia for Treatment of Severe Depression

NCT02935647
COMPLETED Phase 2

Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma

NCT04062032
COMPLETED NA

Does Overpractice Improve Motor Learning?

NCT02898701
COMPLETED NA

Mechanisms of Skeletal Muscle Insulin Resistance in Older Adults

NCT02971098
TERMINATED NA

Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation

NCT02935465
COMPLETED Phase 1

A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers

NCT02613650
COMPLETED

Measuring Ability of Healthy Volunteers to Power a Bicycle-powered Oxygen Concentrator

NCT02909738
COMPLETED Phase 4

RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC

NCT02175030
TERMINATED NA

Spectacle Tints and Thin-Films for Migraine

NCT02720211
COMPLETED NA

The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease

NCT02593812
COMPLETED Early Phase 1

Radiation Dose in Humans From Orally Administered Tc99m-Heparin

NCT04069429
COMPLETED NA

Social Skills in Children With ASD and Process Drama

NCT02850666
COMPLETED NA

Family Lifestyle Actions and Risk Education Study

NCT02846714
TERMINATED

Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial

NCT02781220
COMPLETED Early Phase 1

LIA in Hip Arthroscopy Patients

NCT03070054
COMPLETED

Implications for Management of PET Amyloid Classification Technology

NCT02778971
COMPLETED

Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle

NCT02786888
COMPLETED Phase 1

Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

NCT02687204
COMPLETED Early Phase 1

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

NCT02704052
COMPLETED NA

The Role of an Attention Demanding Activity for Priming Motor Learning

NCT02714647
COMPLETED NA

Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD

NCT03024424
COMPLETED Early Phase 1

Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling

NCT02684747
TERMINATED NA

Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate

NCT02743650
COMPLETED

Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

NCT03195179
COMPLETED

Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury

NCT02616081
COMPLETED NA

Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease

NCT02600858
COMPLETED NA

Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary Care

NCT02602535
COMPLETED Phase 4

Intranasal Delivery of Testosterone and Its Effect on Doping Markers

NCT02611154
COMPLETED NA

Psychosocial Support for Acute Hospital Pain and Distress

NCT02590029
COMPLETED

Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee

NCT02626559
COMPLETED

Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus

NCT03551600
COMPLETED

Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers

NCT02886312
COMPLETED NA

Motherhood and Pelvic Health (MAP Study)

NCT02512016
COMPLETED NA

TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)

NCT02413216
COMPLETED NA

Mobile Decision Support System for Nurse Management of Neuromodulation Therapy

NCT02474459
COMPLETED NA

Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women

NCT02796586
COMPLETED NA

Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring

NCT02379351
← Previous Page 10 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

Therapeutic Areas

Low Back Pain 8
Pain 8
Breast Cancer 8
Contraception 6
Stroke 6
Obesity 6
Metastatic Castration-Resistant Prostate Cancer 5
Gynecologic Cancer 4
Skin Cancer 4
Sleep 4

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.